156 related articles for article (PubMed ID: 26870299)
1. Predicting the failure of retrograde ureteral stent insertion for managing malignant ureteral obstruction in outpatients.
Wang JY; Zhang HL; Zhu Y; Qin XJ; Dai BO; Ye DW
Oncol Lett; 2016 Jan; 11(1):879-883. PubMed ID: 26870299
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
3. Predicting the success of retrograde stenting for managing ureteral obstruction.
Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
[TBL] [Abstract][Full Text] [Related]
4. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
Matsuura H; Arase S; Hori Y
Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
[TBL] [Abstract][Full Text] [Related]
5. [The Predictive Factors of Stent Failure in the Treatment of Malignant Extrinsc Ureteral Obstruction Using Internal Ureteral Stents].
Matsuura H; Arase S; Hori Y; Tochigi H
Hinyokika Kiyo; 2017 Dec; 63(12):503-507. PubMed ID: 29370660
[TBL] [Abstract][Full Text] [Related]
6. Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.
Kim SH; Park B; Joo J; Joung JY; Seo HK; Chung J; Lee KH
PLoS One; 2017; 12(9):e0184965. PubMed ID: 28931043
[TBL] [Abstract][Full Text] [Related]
7. Predicting factors for stent failure-free survival in patients with a malignant ureteral obstruction managed with ureteral stents.
Yu SH; Ryu JG; Jeong SH; Hwang EC; Jang WS; Hwang IS; Yu HS; Kim SO; Jung SI; Kang TW; Kwon DD; Park K; Hwang JE; Kim GS
Korean J Urol; 2013 May; 54(5):316-21. PubMed ID: 23700497
[TBL] [Abstract][Full Text] [Related]
8. Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy.
Elsamra SE; Motato H; Moreira DM; Waingankar N; Friedlander JI; Weiss G; Smith AD; Okeke Z
J Endourol; 2013 Oct; 27(10):1297-302. PubMed ID: 23829600
[TBL] [Abstract][Full Text] [Related]
9. Comparison between Antegrade versus Retrograde Ureteral Stent Placement for Malignant Ureteral Obstruction.
Kim HJ; Yoon CJ; Lee S; Lee JH; Choi WS; Lee CH
J Vasc Interv Radiol; 2022 Oct; 33(10):1199-1206. PubMed ID: 35809804
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and prognostic factors associated with internal ureteral stent placement for malignant extrinsic ureteral obstruction.
Matsuura H; Arase S; Hori Y
Support Care Cancer; 2020 Dec; 28(12):5743-5750. PubMed ID: 32206969
[TBL] [Abstract][Full Text] [Related]
11. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.
Chung SY; Stein RJ; Landsittel D; Davies BJ; Cuellar DC; Hrebinko RL; Tarin T; Averch TD
J Urol; 2004 Aug; 172(2):592-5. PubMed ID: 15247739
[TBL] [Abstract][Full Text] [Related]
12. Renal function is associated with prognosis in stent-change therapy for malignant ureteral obstruction.
Yoon JH; Park S; Park S; Moon KH; Cheon SH; Kwon T
Investig Clin Urol; 2018 Nov; 59(6):376-382. PubMed ID: 30402570
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Stent Failure for Malignant Ureteral Obstruction in Non-Urological Cancer.
Heo JE; Jeon DY; Lee J; Han HH; Jang WS
Yonsei Med J; 2023 Nov; 64(11):665-669. PubMed ID: 37880847
[TBL] [Abstract][Full Text] [Related]
14. Risk factors in the prediction of long-term patency of Resonance metallic ureteric stent in malignant ureteric obstruction.
Ho BSH; Chiu PKF; Lam W; Wong JHF; Wong CKW; Lai TCT; Tsang CF; Ng ATL; Chan CK; Ma WK; Ng CF; Tsu JHL
BJUI Compass; 2020 May; 1(2):74-81. PubMed ID: 35474710
[TBL] [Abstract][Full Text] [Related]
15. The Role of Tandem Double-J Ureteral Stents in the Management of Malignant Ureteral Obstruction.
Varnavas M; Bolgeri M; Mukhtar S; Anson K
J Endourol; 2016 Apr; 30(4):465-8. PubMed ID: 26585189
[TBL] [Abstract][Full Text] [Related]
16. Early Application of Permanent Metallic Mesh Stent in Substitution for Temporary Polymeric Ureteral Stent Reduces Unnecessary Ureteral Procedures in Patients With Malignant Ureteral Obstruction.
Kim KH; Cho KS; Ham WS; Hong SJ; Han KS
Urology; 2015 Sep; 86(3):459-64. PubMed ID: 26142711
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of ureteral stenting for managing extrinsic ureteral obstruction due to gynecological and gastrointestinal cancer].
Takehara K; Onita T; Mochizuki Y; Miyata Y; Igawa T; Sakai H
Hinyokika Kiyo; 2014 Jan; 60(1):13-6. PubMed ID: 24594767
[TBL] [Abstract][Full Text] [Related]
18. Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients.
Liu KL; Lee BC; Ye JD; Chang YH; Chang CC; Huang KH; Lee YJ; Chang YC
Eur Radiol; 2019 Feb; 29(2):628-635. PubMed ID: 29974220
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for overall survival in malignant ureteral obstruction.
Mason JB; Creswell M; Egan J; Dall C; Sholklapper T; Galloway LA; Orzel J; Lee H; Desale S; Stamatakis L
Can J Urol; 2022 Jun; 29(3):11162-11169. PubMed ID: 35691038
[TBL] [Abstract][Full Text] [Related]
20. Unveiling the Challenges in Tandem Ureteral Stent Management for Malignant Ureteral Obstruction: Failure Rate, Risk Factors, and Durability of Their Replacement.
Carmona O; Shvero A; Zilberman DE; Dotan ZA; Kleinmann N
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
